| (Values in U.S. Thousands) | Sep, 2019 | Jun, 2019 | Mar, 2019 | Dec, 2018 | Sep, 2018 |
| Sales | 2,930 | 2,610 | 2,470 | 2,280 | 1,810 |
| Sales Growth | +12.26% | +5.67% | +8.33% | +25.97% | +9.70% |
| Net Income | -1,120 | -1,550 | -1,220 | -1,220 | -1,430 |
| Net Income Growth | +27.74% | -27.05% | unch | +14.69% | +23.94% |
Mri Interventions (MRIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
MRI Interventions Inc. operates as a medical device company. It develops platforms for invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging. The company focuses on research and product development in the field of interventional magnetic resonance imaging. MRI Interventions Inc. is based in Irvine, California.